2017 Jan 05
When should you be screened? Important cancer tests you shouldn't miss
Felice Schnoll-Sussman, M.D., appeared on the TODAY Show to review cancer screening guidelines by age Read more
2017 Jan 04
Copper toned research trial offers new hope in finding a cure for cancer
TV coverage of Linda Vahdat's copper depletion trial, and the crowdfunding initiative she has started to fund it. Read more
2017 Jan 04
Softening of tumor tissue could aid in cancer drug delivery
An Ithaca-NYC team has found that the stiffening of the matrix surrounding a metastatic tumor plays a key role in the vascular makeup of the tumor that promotes tumor growth and mobility by keeping drugs out. Read more
2016 Dec 29
Incidence of metastatic prostate cancer in older men increases following drop in PSA screening
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011, according to new research from Jim Hu, M.D. Read more
2016 Dec 28
Breast center launches innovative crowdfunding campaign to fund clinical trial
Linda Vahdat, M.D., is turning to the public to help fund a trial for a new triple negative breast cancer treatment involving a simple oral medication that reduces copper levels in the patient’s body Read more
2016 Dec 24
The profound impacts of patients
Jeffrey Greenfield, M.D., Ph.D., shared his story about how one patient had a profound impact on his career. Read more
2016 Dec 22
7 Warning Signs Of A Brain Tumor You Should Know
Neurosurgeon Theodore Schwartz, M.D., shares some brain tumor symptoms. Read more
2016 Dec 21
Metabolic pathways may provide opportunity for novel therapeutic targeting in neuro-oncology
Howard Fine, M.D., discusses the investigation of metabolic pathways in brain tumors to identify potential new therapeutic targets. Read more
2016 Dec 21
Research reveals codes that control protein expression
An internal code in messenger RNA predetermines how much protein they will produce, according to a new study by Samie Jaffrey. Read more
2016 Dec 20
End-of-life discussions held at ‘astounding’ infrequency
Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to a study by Holly Prigerson, Ph.D., and colleagues. Read more
2016 Dec 20
New model could benefit liver cancer transplant patients
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease recurrence, according to new research from Weill Cornell Medicine doctors. Read more
2016 Dec 16
New guidelines aim to standardize interpretation and reporting of somatic cancer variants
Olivier Elemento, Ph.D., comments on a new set of guidelines released by the Association for Molecular Pathology. Read more
2016 Dec 15
Corrupted tumor blood vessels spawn cancer stem cells
The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy, according to a new study by a team of researchers led by Shahin Rafii. Read more
2016 Dec 13
NYC biotech industry to get big boost from new de Blasio initiative
Harold Varmus, M.D., was named as co-chair of a new Life Sciences Advisory Council for the city of New York Read more
2016 Dec 12
The Cancer Lottery
Harold Varmus, M.D., discusses some of the "lost opportunities" in cancer genomics. Read more
2016 Dec 10
Greater collaboration may improve outcomes in pancreatic cancer
Two recent features highlighted the efforts of Allyson Ocean, M.D., to involve patients in their treatments for pancreatic cancer. Read more
2016 Dec 09
Vahdat presents promising new treatment for triple negative breast cancer
Linda Vahdat, M.D., MBA, presented promising results of the use of IMMU-132 to treat triple-negative breast cancer. Read more
2016 Dec 09
The P.A.Th. to better models
Researchers at Weill Cornell Medicine and the Cornell University College of Veterinary Medicine have undertaken an ambitious $5 million project to create new model systems that accurately reflect the biology, genetics and tumor-host interactions of difficult-to-treat blood cancers. Read more
2016 Dec 09
Hematologists present research at 2016 ASH conference
Thousands of hematologists gathered in San Diego on Dec. 3 for the 58th Annual Meeting of the American Society of Hematology (ASH), and Weill Cornell Medicine/NewYork-Presbyterian was well represented. Read more
2016 Dec 07
Infections after prostate biopsy continue to rise
Infectious complication rates following prostate biopsies continue to increase, despite decreased use of the procedures, according to Jim Hu, M.D. Read more
